A detailed history of First National Bank Of Omaha transactions in United Therapeutics Corp stock. As of the latest transaction made, First National Bank Of Omaha holds 5,725 shares of UTHR stock, worth $2.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,725
Previous 5,931 3.47%
Holding current value
$2.1 Million
Previous $1.89 Million 8.58%
% of portfolio
0.14%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$311.04 - $363.55 $64,074 - $74,891
-206 Reduced 3.47%
5,725 $2.05 Million
Q2 2024

Aug 15, 2024

BUY
$228.26 - $319.04 $1.35 Million - $1.89 Million
5,931 New
5,931 $1.89 Million
Q4 2017

Feb 05, 2018

BUY
$118.58 - $151.28 $3.79 Million - $4.84 Million
31,991
31,991 $4.41 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.